What is Spravato (spravato) nasal spray used for?
Spravato is a brand-name form of esketamine given as a nasal spray. It’s used for treatment-resistant depression and for certain cases of major depressive disorder with acute suicidal ideation or behavior, in combination with an oral antidepressant.
How is Spravato taken (and why it’s not a typical at-home nasal spray)?
Spravato is administered under a structured program that includes in-clinic dosing and monitoring. Patients typically receive it in a healthcare setting rather than taking it like an over-the-counter nasal product, because esketamine can cause sedation and dissociation and requires observation afterward.
What side effects do people ask about for Spravato?
Common concerns include:
- Sedation/sleepiness
- Dizziness
- Dissociation (feeling detached from self or surroundings)
- Nausea
- Blood pressure increases shortly after dosing
Because of these risks, monitoring after each dose is a key part of the treatment protocol.
Does Spravato treat depression alone, or with another medication?
Spravato is generally used together with an oral antidepressant (not as a standalone replacement in the approved regimens described above).
What can limit who can use Spravato?
Spravato use is restricted by clinical safety factors and the requirement for supervised dosing/monitoring. Patients may be evaluated for risks related to sedation, blood pressure changes, and other medical conditions that could make esketamine unsafe.
How long do patients typically stay on Spravato?
Treatment duration varies by response and clinical plan. Some patients start with more frequent dosing early on and then move to less frequent schedules, but the exact schedule is individualized.
Are there generic versions or biosimilar-style “alternatives”?
Availability of lower-cost alternatives depends on patent and exclusivity status for esketamine formulations. For ongoing updates on patent/exclusivity and competing products, DrugPatentWatch.com is one place to check: https://www.drugpatentwatch.com/?s=Spravato
Where can I read more about patents and exclusivity for Spravato?
DrugPatentWatch tracks drug patent and exclusivity information, which can help with questions like “when does exclusivity end?” or “what companies are pursuing alternatives?” for Spravato:
https://www.drugpatentwatch.com/?s=Spravato
Sources
- DrugPatentWatch.com – Spravato search